Quest Laboratories Ltd Falls 11.36%: 4 Key Events Shaping the Week

11 May 2026: Quest Laboratories Hits Lower Circuit Amid Heavy Selling

Quest Laboratories Ltd opened the week on a weak note, hitting its lower circuit at Rs.123.40, a 4.97% decline from the previous close. The stock traded within a narrow band, closing at the circuit price due to intense selling pressure and a scarcity of buyers. The total volume was modest at 1.2 lakh shares, reflecting limited investor participation. This sharp fall significantly underperformed the Sensex’s 1.40% decline and the Pharmaceuticals & Biotechnology sector’s 0.41% drop, indicating company-specific concerns driving the sell-off.

Technically, the stock remained above its longer-term moving averages but fell below its 5-day and 20-day averages, signalling short-term weakness. The decline was exacerbated by a 31.49% drop in delivery volumes compared to the five-day average, suggesting waning investor conviction. Despite the micro-cap’s limited liquidity, the selling pressure overwhelmed available bids, triggering the circuit breaker and halting further declines.

12 May 2026: Continued Downtrend with Another Lower Circuit Hit

The downward momentum persisted on 12 May as Quest Laboratories again hit its lower circuit, closing at Rs.117.25, down 4.98% on the day. The stock traded between Rs.117.25 and Rs.120.00, with a total volume of 1.13 lakh shares. This decline outpaced the Sensex’s 2.19% fall and the sector’s 0.66% drop, underscoring intensified selling pressure specific to the stock.

Investor participation showed signs of tension, with delivery volumes rising 37.5% from the five-day average, indicating increased settlement activity possibly linked to panic selling. The stock’s Mojo Score remained positive at 74.0, but its Mojo Grade was downgraded from Strong Buy to Buy on 11 May, reflecting a more cautious outlook that may have contributed to the selling pressure. The stock’s technical position remained weak, trading below short-term moving averages despite holding above longer-term levels.

14 May 2026: Sharp Decline Despite Sector Gains

On 14 May, Quest Laboratories plunged again to hit its lower circuit at Rs.110.00, a 4.92% drop, contrasting sharply with the Pharmaceuticals & Biotechnology sector’s 2.33% gain and the Sensex’s 1.01% rise. The stock traded between Rs.107.10 and Rs.113.05, with a volume of 87,600 shares. This underperformance amid a broadly bullish sector environment highlighted company-specific challenges and heightened investor anxiety.

Technically, the stock was below all major moving averages except the 200-day, signalling medium-term bearish momentum. Liquidity remained modest but sufficient for retail trades, yet the heavy selling overwhelmed bids, triggering the circuit breaker. The Mojo Grade downgrade and the micro-cap status likely contributed to the volatility and selling pressure. Delivery volumes increased slightly by 0.23%, indicating some investor willingness to hold despite the sharp fall.

15 May 2026: Strong Rebound with Upper Circuit Hit

In a dramatic turnaround, Quest Laboratories surged on 15 May to hit its upper circuit at Rs.116.05, gaining 4.98% and outperforming the sector’s 0.21% and the Sensex’s 0.36% declines. The stock traded with a volume of 34,800 shares and a turnover of Rs.0.40 crore, reflecting robust buying interest. Delivery volumes on 14 May had risen to 1.04 lakh shares, signalling increased investor confidence.

Technically, the stock’s last traded price was above its 100-day and 200-day moving averages but remained below shorter-term averages, suggesting potential near-term resistance. The upper circuit triggered a regulatory trading freeze, indicating strong latent demand and unfilled buy orders. This rebound may reflect bargain hunting or repositioning after several days of heavy selling.

Daily Price Performance vs Sensex

Key Takeaways

The week’s price action for Quest Laboratories Ltd was dominated by extreme volatility, with three lower circuit hits followed by a strong upper circuit close. The stock’s 11.36% weekly decline significantly outpaced the Sensex’s 2.63% fall, reflecting company-specific selling pressure amid a generally mixed market backdrop.

Despite the sharp declines, the stock maintained its position above long-term moving averages, suggesting underlying fundamental support. The downgrade in Mojo Grade from Strong Buy to Buy on 11 May likely contributed to investor caution and selling pressure. Delivery volumes fluctuated, indicating shifts between panic selling and renewed investor interest.

The upper circuit on 15 May signals potential buying interest and a possible technical rebound, although the stock remains below key short-term averages. Liquidity constraints typical of micro-cap stocks amplified price swings, underscoring the need for careful monitoring of volume and price trends.

Conclusion

Quest Laboratories Ltd’s week was marked by significant price swings driven by heavy selling and subsequent buying interest. The multiple lower circuit hits highlight the challenges micro-cap stocks face in volatile markets, including liquidity limitations and heightened sensitivity to sentiment shifts. The strong rebound on the final day offers a glimpse of recovery potential, but the stock’s technical and fundamental indicators suggest a cautious outlook in the near term.

Investors should remain attentive to upcoming corporate developments, sector trends, and broader market conditions to better gauge the stock’s trajectory. The combination of a positive Mojo Score and recent rating downgrade calls for a balanced approach, weighing both risks and opportunities inherent in this pharmaceutical micro-cap.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →